Viewing Study NCT03071757


Ignite Creation Date: 2025-12-24 @ 6:39 PM
Ignite Modification Date: 2026-02-25 @ 11:01 PM
Study NCT ID: NCT03071757
Status: COMPLETED
Last Update Posted: 2022-04-28
First Post: 2017-03-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: AbbVie
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M16-074
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators